O'Loughlin Steve 4
4 · Actinium Pharmaceuticals, Inc. · Filed Mar 8, 2018
Insider Transaction Report
Form 4
O'Loughlin Steve
Chief Financial Officer
Transactions
- Other
Common Stock
2018-03-06$0.50/sh+10,000$5,000→ 13,500 total - Other
Series B Warrants
2018-03-06$0.50/sh+7,500$3,750→ 7,500 totalExercise: $0.70From: 2018-03-06Exp: 2020-09-06→ Common Stock (7,500 underlying) - Other
Series A Warrants
2018-03-06$0.50/sh+2,500$1,250→ 2,500 totalExercise: $0.60From: 2018-03-06Exp: 2019-03-06→ Common Stock (2,500 underlying)